Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Annu Int Conf IEEE Eng Med Biol Soc ; 2017: 4163-4166, 2017 Jul.
Article in English | MEDLINE | ID: mdl-29060814

ABSTRACT

Electrical cortical stimulation (ECS) is often used in presurgical evaluation procedures for patients suffering from pharmacoresistant epilepsy. Real-time functional mapping (RTFM) is an alternative brain mapping methodology that can accompany traditional functional mapping approaches like ECS. In this paper, we present a combined RTFM/ECS system that aims to exploit the common ground and the advantages of the two procedures for improved time/effort effectiveness, patients' experience and safety. Using the RTFM and ECS data from four patients who suffer epilepsy, we demonstrate that the RTFM-guided ECS procedure hypothetically reduces the number of electrical stimulations necessary for eloquent cortex detection by 40%.


Subject(s)
Epilepsy , Brain Mapping , Cerebral Cortex , Computer Systems , Electric Stimulation , Electroencephalography , Humans , Magnetic Resonance Imaging
3.
Curr Pharm Des ; 15(22): 2573-93, 2009.
Article in English | MEDLINE | ID: mdl-19689329

ABSTRACT

Cognitive dysfunction is considered to be a core feature in schizophrenia. It is believed that antipsychotic drugs, especially atypical ones, could improve cognitive functions in schizophrenia patients. Auditory event-related potentials (ERPs) such as mismatch negativity (MMN) and P300 response are potential candidates for objective investigation of pre-attentional and attention-dependent processing in schizophrenia patients, respectively. Both these responses were found to be altered in schizophrenia. Moreover, neurotransmitters play important role in generation of MMN and P300 components. Therefore, these ERPs are potential candidates for monitoring the cognitive changes caused by neurochemical modulation during antipsychotic treatment in schizophrenia patients. In addition, neurochemical ERP generation mechanisms discovered during drug-challenge studies in healthy subjects could explain these ERP findings in patients. To date, no effect of antipsychotic treatment on MMN was observed, whereas certain antipsychotics (e.g. clozapine) could modulate P300 response. At the same time, adjunctive glutamate-system affecting therapy seems to influence MMN response. The explanation of these phenomena could be a weak relationship between dopaminergic activities and MMN response and a strong connection between glutamate NMDA receptors and MMN generation. As to the P300 component, because of the multiple generators, it is more sensitive to the influences of different neurochemical activities. In the future, the combination of transcranial magnetic stimulation (TMS) and functional magnetic resonance imaging (fMRI) with electroencephalography (EEG) will open new possibilities for understanding the drug-induced changes on the neural substrates of information processing in schizophrenia patients.


Subject(s)
Antipsychotic Agents/pharmacology , Cognition/drug effects , Evoked Potentials/drug effects , Magnetoencephalography/methods , Schizophrenia/drug therapy , Schizophrenic Psychology , Antipsychotic Agents/therapeutic use , Brain/drug effects , Brain/physiopathology , Cognition/physiology , Dopamine/physiology , Electroencephalography/methods , Evoked Potentials/physiology , Evoked Potentials, Auditory , Glutamic Acid/physiology , Humans , Psychotropic Drugs/pharmacology , Psychotropic Drugs/therapeutic use , Schizophrenia/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...